Contact Information
Email
d****@transitionbio.com
Unlock
Company Information
Company
Transition Bio, Inc.
Total Funding
108351426.0
Technologies
Outlook
Microsoft Office 365
WordPress.org
Mobile Friendly
Google Tag Manager
Apache
Python
Keywords
biotechnology research
drug discovery
condensate technology
molecular platform
biomolecular condensates
oncogenic signaling
rna foci
molecular screening
high throughput screening
drug development
biophysical assays
target validation
cell imaging
machine learning
microfluidics
novel therapies
binding mechanisms
therapeutic hypothesis
rare diseases
oncology programs
ai-based discovery
small molecule design
biotechnology
proteins
neurodegenerative diseases
target engagement
sequestered biomolecules
cellular processes
disease mechanisms
biomaterials
serious diseases
translational sciences
pharmacology
indication selection
hit identification
biophysics
protein interactions
high-content imaging
health challenges
biological targets
chemistry
genomics
protein aggregation
soft matter physics
cellular homeostasis
phase screening
molecular lens
transcriptional assemblies
innovative therapeutics
artificial intelligence
information technology & services
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans